Which condition is listed for dispensing Schedule III, IV, and V for maintenance or detox?

• A. FDA approval (buprenorphine)
• B. No methadone
• C. No X DEA #
• D. One-time eight-hour training (pharmacists can prescribe under CPA with training)

Answer: (D)

When pharmacists are allowed to participate in maintenance or detox for opioid use disorder, the enabling condition is a collaborative practice arrangement paired with specific training. The one-time eight-hour training qualifies a pharmacist to prescribe or dispense Schedule III–V medications under a CPA with physician oversight. This training equips them to safely manage maintenance or detox therapy (for example with buprenorphine) within that collaborative framework.

Other options don’t establish the required framework: FDA approval governs drug approval, not the pharmacist’s ability to participate in maintenance/detox under a CPA; methadone for maintenance is typically restricted to federally licensed treatment programs; and an X DEA number is needed for physicians treating addiction, not the CPA-trained pharmacist arrangement described here.